Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 12;14(10):702.
doi: 10.3390/cells14100702.

The Competitive Interaction of Alveolar Wall Distention with Elastin Crosslinking: A Mechanistic Approach to Emergent Phenomena in Pulmonary Emphysema

Affiliations
Review

The Competitive Interaction of Alveolar Wall Distention with Elastin Crosslinking: A Mechanistic Approach to Emergent Phenomena in Pulmonary Emphysema

Jerome Cantor. Cells. .

Abstract

Emergent phenomena arise from the interaction of competing forces at multiple scale levels, resulting in complex outcomes that are not readily apparent from analyzing the individual components. Regarding biological systems, when a critical threshold is reached, a phase transition occurs, producing a spontaneous system reorganization characterized by recognizable molecular, microscopic, and macroscopic changes. The current paper explores the emergent phenomena underlying the pathogenesis of pulmonary emphysema, a disease characterized by progressive airspace enlargement. The competitive relationship between mechanical strain imposed on alveolar walls and a countervailing increase in elastin crosslinking to prevent alveolar wall rupture leads to airspace enlargement as the balance between these two processes shifts toward increasing lung injury. This phase transition is also accompanied by an accelerated release of peptide-free elastin-specific desmosine crosslinks as the mean alveolar wall diameter begins to increase, suggesting their potential use as a biomarker for the molecular changes that precede the development of pulmonary emphysema. Early detection of the disease would allow more timely therapeutic intervention involving multiple agents that address the complexities of emergent phenomena at different scale levels.

Keywords: desmosine; elastin; emergent phenomena; hyaluronan; pulmonary emphysema.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Illustration showing the increase in elastin crosslinking (intersecting lines) following repeated injury and repair of elastic fibers. The haphazard nature of this process results in uneven distribution of mechanical forces, which contributes to alveolar wall injury.
Figure 2
Figure 2
The desmosine and isodesmosine crosslinks of elastin are formed by the condensation of four lysine residues on adjacent peptides. The difference between them is the location of the lysyl side chains on the central pyridinium ring. Reprinted with permission of Creative Commons (https://creativecommons.org/licenses/by-sa/4.0/ (accessed on 10 February 2025)).
Figure 3
Figure 3
Graph showing the marked increase in lung content of free DID as the alveolar diameter exceeds 400 µm. This finding is consistent with the nonlinear features of emergent phenomena. Reprinted with permission from [14].
Figure 4
Figure 4
Graph showing the marked increase in DID density as alveolar diameter exceeds 300 µm. Beyond 400 µm, the density plateaus as the repair process undergoes a decompensatory phase due to progressive distention and rupture of alveolar walls. Reprinted with permission from [14].
Figure 5
Figure 5
Photomicrograph showing the fragmentation (arrows) and unraveling of elastic fibers (arrowhead). Reprinted with permission from [22].
Figure 6
Figure 6
HA is a long-chain polysaccharide composed of repeating disaccharide units of glucuronic acid and N-acetylglucosamine. When inhaled as an aerosol, it binds to alveolar elastic fibers and protects them from elastases released by inflammatory cells. Reprinted with permission from [36].

References

    1. Mecham R.P. Elastin in lung development and disease pathogenesis. Matrix Biol. 2018;73:6–20. doi: 10.1016/j.matbio.2018.01.005. - DOI - PMC - PubMed
    1. Chapman K.R. Bench to Bedside and Back: The Evolving Story of Alpha-1 Antitrypsin Deficiency. Am. J. Respir. Cell Mol. Biol. 2020;63:403–404. doi: 10.1165/rcmb.2020-0243ED. - DOI - PMC - PubMed
    1. Sandhaus R.A., Turino G. Neutrophil elastase-mediated lung disease. COPD J. Chronic Obstr. Pulm. Dis. 2013;10((Suppl. 1)):60–63. doi: 10.3109/15412555.2013.764403. - DOI - PubMed
    1. Feng T., Cao J., Ma X., Wang X., Guo X., Yan N., Fan C., Bao S., Fan J. Animal models of chronic obstructive pulmonary disease: A systematic review. Front. Med. 2024;11:1474870. doi: 10.3389/fmed.2024.1474870. - DOI - PMC - PubMed
    1. Burgess J.K., Gosens R. Mechanotransduction and the extracellular matrix: Key drivers of lung pathologies and drug responsiveness. Biochem. Pharmacol. 2024;228:116255. doi: 10.1016/j.bcp.2024.116255. - DOI - PubMed

LinkOut - more resources